SE0200449D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
SE0200449D0
SE0200449D0 SE0200449A SE0200449A SE0200449D0 SE 0200449 D0 SE0200449 D0 SE 0200449D0 SE 0200449 A SE0200449 A SE 0200449A SE 0200449 A SE0200449 A SE 0200449A SE 0200449 D0 SE0200449 D0 SE 0200449D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
SE0200449A
Other languages
Swedish (sv)
Inventor
Agneta Hallgren
Kristina Roos
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0200449A priority Critical patent/SE0200449D0/en
Publication of SE0200449D0 publication Critical patent/SE0200449D0/en

Links

SE0200449A 2002-02-13 2002-02-13 Pharmaceutical formulation SE0200449D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0200449A SE0200449D0 (en) 2002-02-13 2002-02-13 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200449A SE0200449D0 (en) 2002-02-13 2002-02-13 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
SE0200449D0 true SE0200449D0 (en) 2002-02-13

Family

ID=20286975

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200449A SE0200449D0 (en) 2002-02-13 2002-02-13 Pharmaceutical formulation

Country Status (1)

Country Link
SE (1) SE0200449D0 (en)

Similar Documents

Publication Publication Date Title
PT1501534E (en) PHARMACEUTICAL FORMULATIONS
NO20033384D0 (en) Pharmaceutical formulation
DK3536344T3 (en) SUPERFIN FORMOTHER FORMULATION
NO20033785D0 (en) Pharmaceutical formulation
NO20033556L (en) Pharmaceutical Formulations
ATE336264T1 (en) DISPERSIBLE PHARMACEUTICAL COMPOSITIONS
FI20011478A (en) Pharmaceutical composition
DE602004017700D1 (en) TRANSMUKOSEN ADMINISTRATION
PT1467724E (en) AGOMELATIN ORODISPERSAVEL PHARMACEUTICAL COMPOSITION
NO20035627D0 (en) Pharmaceutical formulation
DK1587478T3 (en) PHARMACEUTICAL COMPOSITION
DK1596870T3 (en) High-dose inter-radonate formulation
FI20022128A0 (en) Pharmaceutical composition
PT1558263E (en) PROLONGED LIBERATION PHARMACEUTICAL COMPOSITION
NO20043576L (en) Pharmaceutical formulation comprising melatonin
NO20041485L (en) Pharmaceutical formulation comprising (R) -bicalutamide
NO20034952D0 (en) Pharmaceutical compounds
IS7581A (en) A pharmaceutical composition
NO20044164L (en) Pharmaceutical compositions
SE0201660D0 (en) Pharmaceutical formulation
SE0200449D0 (en) Pharmaceutical formulation
DE112004001429D2 (en) Pharmaceutical agent
NO20041236L (en) Pharmaceutical Formulation
SE0102069D0 (en) Pharmaceutical formulation
SE0101325D0 (en) Pharmaceutical formulation